Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 1:8:337.
doi: 10.3389/fendo.2017.00337. eCollection 2017.

One-third of an Archivial Series of Papillary Thyroid Cancer (Years 2007-2015) Has Coexistent Chronic Lymphocytic Thyroiditis, Which Is Associated with a More Favorable Tumor-Node-Metastasis Staging

Affiliations

One-third of an Archivial Series of Papillary Thyroid Cancer (Years 2007-2015) Has Coexistent Chronic Lymphocytic Thyroiditis, Which Is Associated with a More Favorable Tumor-Node-Metastasis Staging

Antonio Ieni et al. Front Endocrinol (Lausanne). .

Abstract

The significance and impact of the coexistence of chronic lymphocytic thyroiditis (CLT) with thyroid cancer is still debated. To verify the influence of CLT on papillary thyroid cancer (PTC), we retrospectively collected 505 PTC cases and analyzed age at diagnosis, sex, size, lymph node status, and staging. We found that CLT was present in 168 PTC (33.3%). Compared with the 337 patients without CLT (non-CLT), CLT patients were younger (44.42 ± 13.72 vs. 47.21 ± 13.76 years, P = 0.03), had smaller tumors (9.39 ± 6.10 vs. 12 ± 9.71 mm, P = 0.002), and lower rate of lymph node metastases (12.5 vs. 21.96%, P = 0.01, OR = 0.508). Tumor-node-metastasis (TNM) staging (T1a through T4) was more favorable for the CLT group compared to the non-CLT group (for instance, T1a = 65.5 vs. 49.8%, T3 = 4.8 vs. 23.4%). This study shows that one in three patients with PTC harbors CLT, which is associated with a more favorable TNM staging, consistently with a favorable outlook of PTC.

Keywords: autoimmune thyroiditis; autoimmunity; cancer; chronic lymphocytic thyroiditis; papillary thyroid cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age distribution of all 505 patients with papillary thyroid cancer (A) and the two groups with [n = 168 (B)] or without [n = 337 (C)] chronic lymphocytic thyroiditis.
Figure 2
Figure 2
Comparison between patients’ age according to sex and presence (black bars) or absence (white bars) of chronic lymphocytic thyroiditis (CLT). Only significant (P < 0.05) or borderline significant (P between 0.05 and 0.10) statistical differences are reported. Symbols: *P = 0.03; §P = 0.058; ^P = 0.02.
Figure 3
Figure 3
Frequency of the seven variants of papillary thyroid cancer (A), and corresponding distribution of age (B–H).
Figure 3
Figure 3
Frequency of the seven variants of papillary thyroid cancer (A), and corresponding distribution of age (B–H).
Figure 4
Figure 4
Comparison between age of patients according to histotype and presence (black bars) or absence (white bars) of chronic lymphocytic thyroiditis (CLT). The striped bars represent all patients. Note that only the three most frequent histotypes are reported (see Figure 3A). Only significant (P < 0.05) and borderline significant (P between 0.05 and 0.10) statistical differences are reported. Symbols: *P = 0.03; §P = 0.03; ^P = 0.004; P = 0.03; #P = 0.06.
Figure 5
Figure 5
Comparison between tumor size according to histotype and presence (black bars) or absence (white bars) of chronic lymphocytic thyroiditis (CLT). The striped bars represent all patients. Note that only the three most frequent histotypes are reported (see Figure 3A). Only significant (P < 0.05) statistical differences are reported. Symbols: *P = 0.002; §P = 0.008; ^P = 0.009.

References

    1. Benvenga S. On the association between Hashimoto’s thyroiditis and papillary thyroid carcinoma: looking 100 years back and, hopefully, fewer years ahead to sort out this association. Thyroid (2013) 23:1180–1.10.1089/thy.2013.0126 - DOI - PubMed
    1. Benvenga S, Trimarchi F. Changed presentation of Hashimoto’s thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid (2008) 18:429–41.10.1089/thy.2007.0234 - DOI - PubMed
    1. Arena S, Latina A, Baratta R, Burgio G, Gullo D, Benvenga S. Chronic lymphocytic thyroiditis: could it be influenced by a petrochemical complex? Data from a cytological study in South-Eastern Sicily. Eur J Endocrinol (2015) 172:383–9.10.1530/EJE-14-0864 - DOI - PubMed
    1. Latina A, Gullo D, Trimarchi F, Benvenga S. Hashimoto’s thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer. PLoS One (2013) 8:e55450.10.1371/journal.pone.0055450 - DOI - PMC - PubMed
    1. Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S. Hashimoto’s thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid (2013) 23:142–50.10.1089/thy.2012.0554 - DOI - PMC - PubMed

LinkOut - more resources